company background image
300439 logo

Medicalsystem Biotechnology SZSE:300439 Stock Report

Last Price

CN¥9.37

Market Cap

CN¥3.6b

7D

-6.1%

1Y

-25.0%

Updated

27 Mar, 2024

Data

Company Financials

Medicalsystem Biotechnology Co., Ltd

SZSE:300439 Stock Report

Market Cap: CN¥3.6b

300439 Stock Overview

Medicalsystem Biotechnology Co., Ltd. provides clinical diagnostics reagents and instruments in China.

300439 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance4/6
Financial Health6/6
Dividends3/6

Medicalsystem Biotechnology Co., Ltd Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Medicalsystem Biotechnology
Historical stock prices
Current Share PriceCN¥9.37
52 Week HighCN¥12.97
52 Week LowCN¥7.28
Beta0.32
1 Month Change0.11%
3 Month Change-18.38%
1 Year Change-24.98%
3 Year Change-58.15%
5 Year Change-46.06%
Change since IPO-29.03%

Recent News & Updates

Recent updates

Shareholder Returns

300439CN BiotechsCN Market
7D-6.1%-6.3%-4.9%
1Y-25.0%-21.2%-16.6%

Return vs Industry: 300439 underperformed the CN Biotechs industry which returned -20.7% over the past year.

Return vs Market: 300439 underperformed the CN Market which returned -14.8% over the past year.

Price Volatility

Is 300439's price volatile compared to industry and market?
300439 volatility
300439 Average Weekly Movement7.3%
Biotechs Industry Average Movement8.1%
Market Average Movement8.2%
10% most volatile stocks in CN Market11.5%
10% least volatile stocks in CN Market5.1%

Stable Share Price: 300439's share price has been volatile over the past 3 months.

Volatility Over Time: 300439's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2003n/aJi Hua Zouhttps://www.nbmksw.com

Medicalsystem Biotechnology Co., Ltd. provides clinical diagnostics reagents and instruments in China. The company offers PCR kit, antibody test kit, antigen and antibody test kit, and nucleic acid reagent for COVID-19; automated biochemistry analyzers and bio reagents; hematology analyzers and reagents; urine analyzers; glycated hemoglobin analyzer; blood lipid analyzer; microfluidic biochemical analyzer; POCT; and chemiluminescene immunoassay analyzers. It also provides healthcare services.

Medicalsystem Biotechnology Co., Ltd Fundamentals Summary

How do Medicalsystem Biotechnology's earnings and revenue compare to its market cap?
300439 fundamental statistics
Market capCN¥3.60b
Earnings (TTM)CN¥225.04m
Revenue (TTM)CN¥2.06b

16.0x

P/E Ratio

1.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
300439 income statement (TTM)
RevenueCN¥2.06b
Cost of RevenueCN¥1.19b
Gross ProfitCN¥873.23m
Other ExpensesCN¥648.18m
EarningsCN¥225.04m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

Apr 19, 2024

Earnings per share (EPS)0.59
Gross Margin42.42%
Net Profit Margin10.93%
Debt/Equity Ratio5.8%

How did 300439 perform over the long term?

See historical performance and comparison

Dividends

1.1%

Current Dividend Yield

18%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.